Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1994 Sep;72(3 Suppl):S65–S69. doi: 10.1136/hrt.72.3_suppl.s65

Neuroendocrine activation after myocardial infarction

Jouko Remes 1
PMCID: PMC1025596  PMID: 7946807

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Focaccio A., Volpe M., Ambrosio G., Lembo G., Pannain S., Rubattu S., Enea I., Pignalosa S., Chiariello M. Angiotensin II directly stimulates release of atrial natriuretic factor in isolated rabbit hearts. Circulation. 1993 Jan;87(1):192–198. doi: 10.1161/01.cir.87.1.192. [DOI] [PubMed] [Google Scholar]
  2. Fontana F., Bernardi P., Spagnolo N., Capelli M. Plasma atrial natriuretic factor in patients with acute myocardial infarction. Eur Heart J. 1990 Sep;11(9):779–787. doi: 10.1093/oxfordjournals.eurheartj.a059797. [DOI] [PubMed] [Google Scholar]
  3. Kohno M., Horio T., Yokokawa K., Murakawa K., Yasunari K., Akioka K., Tahara A., Toda I., Takeuchi K., Kurihara N. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med. 1992 Jan;92(1):29–34. doi: 10.1016/0002-9343(92)90011-y. [DOI] [PubMed] [Google Scholar]
  4. Lechleitner P., Genser N., Mair J., Maier J., Artner-Dworzak E., Dienstl F., Puschendorf B. Endothelin-1 in patients with complicated and uncomplicated myocardial infarction. Clin Investig. 1992 Dec;70(12):1070–1072. doi: 10.1007/BF00184545. [DOI] [PubMed] [Google Scholar]
  5. Lechleitner P., Genser N., Mair J., Maier J., Artner-Dworzak E., Dienstl F., Puschendorf B. Plasma immunoreactive endothelin in the acute and subacute phases of myocardial infarction in patients undergoing fibrinolysis. Clin Chem. 1993 Jun;39(6):955–959. [PubMed] [Google Scholar]
  6. Lerman A., Gibbons R. J., Rodeheffer R. J., Bailey K. R., McKinley L. J., Heublein D. M., Burnett J. C., Jr Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet. 1993 May 1;341(8853):1105–1109. doi: 10.1016/0140-6736(93)93125-k. [DOI] [PubMed] [Google Scholar]
  7. Lindpaintner K., Ganten D. The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence. Circ Res. 1991 Apr;68(4):905–921. doi: 10.1161/01.res.68.4.905. [DOI] [PubMed] [Google Scholar]
  8. Lindpaintner K., Niedermaier N., Drexler H., Ganten D. Left ventricular remodeling after myocardial infarction: does the cardiac renin-angiotensin system play a role? J Cardiovasc Pharmacol. 1992;20 (Suppl 1):S41–S47. [PubMed] [Google Scholar]
  9. McAlpine H. M., Morton J. J., Leckie B., Rumley A., Gillen G., Dargie H. J. Neuroendocrine activation after acute myocardial infarction. Br Heart J. 1988 Aug;60(2):117–124. doi: 10.1136/hrt.60.2.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McCance A. J., Thompson P. A., Forfar J. C. Increased cardiac sympathetic nervous activity in patients with unstable coronary heart disease. Eur Heart J. 1993 Jun;14(6):751–757. doi: 10.1093/eurheartj/14.6.751. [DOI] [PubMed] [Google Scholar]
  11. Morita E., Yasue H., Yoshimura M., Ogawa H., Jougasaki M., Matsumura T., Mukoyama M., Nakao K. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation. 1993 Jul;88(1):82–91. doi: 10.1161/01.cir.88.1.82. [DOI] [PubMed] [Google Scholar]
  12. Motwani J. G., McAlpine H., Kennedy N., Struthers A. D. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet. 1993 May 1;341(8853):1109–1113. doi: 10.1016/0140-6736(93)93126-l. [DOI] [PubMed] [Google Scholar]
  13. Ngo L., Vesely D. L., Bissett J. K., Murphy M. L., Dinh H., Sallman A. L., Rico D. M., Winters C. J., Wyeth R. P. Acute and sustained release of the atrial natriuretic factor prohormone N-terminus with acute myocardial infarction. Am J Med Sci. 1991 Mar;301(3):157–164. doi: 10.1097/00000441-199103000-00002. [DOI] [PubMed] [Google Scholar]
  14. Omland T., Bonarjee V. V., Aakvaag A., Aarsland T., Dickstein K. The relationship between early plasma atrial natriuretic factor levels and exercise performance after myocardial infarction. Eur Heart J. 1993 Aug;14(8):1022–1026. doi: 10.1093/eurheartj/14.8.1022. [DOI] [PubMed] [Google Scholar]
  15. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  16. Pfeffer M. A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990 Apr;81(4):1161–1172. doi: 10.1161/01.cir.81.4.1161. [DOI] [PubMed] [Google Scholar]
  17. Remes J., Tikkanen I., Fyhrquist F., Pyörälä K. Neuroendocrine activity in untreated heart failure. Br Heart J. 1991 May;65(5):249–255. doi: 10.1136/hrt.65.5.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Robalino B. D., Petrella R. W., Jubran F. Y., Bravo E. L., Healy B. P., Whitlow P. L. Atrial natriuretic factor in patients with right ventricular infarction. J Am Coll Cardiol. 1990 Mar 1;15(3):546–553. doi: 10.1016/0735-1097(90)90623-w. [DOI] [PubMed] [Google Scholar]
  19. Rouleau J. L., de Champlain J., Klein M., Bichet D., Moyé L., Packer M., Dagenais G. R., Sussex B., Arnold J. M., Sestier F. Activation of neurohumoral systems in postinfarction left ventricular dysfunction. J Am Coll Cardiol. 1993 Aug;22(2):390–398. doi: 10.1016/0735-1097(93)90042-y. [DOI] [PubMed] [Google Scholar]
  20. Stewart D. J., Kubac G., Costello K. B., Cernacek P. Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J Am Coll Cardiol. 1991 Jul;18(1):38–43. doi: 10.1016/s0735-1097(10)80214-1. [DOI] [PubMed] [Google Scholar]
  21. Swedberg K., Eneroth P., Kjekshus J., Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation. 1990 Nov;82(5):1730–1736. doi: 10.1161/01.cir.82.5.1730. [DOI] [PubMed] [Google Scholar]
  22. Tomoda H. Atrial natriuretic peptide in acute myocardial infarction. Am J Cardiol. 1988 Nov 15;62(16):1122–1123. doi: 10.1016/0002-9149(88)90561-9. [DOI] [PubMed] [Google Scholar]
  23. Tomoda H. Plasma endothelin-1 in acute myocardial infarction with heart failure. Am Heart J. 1993 Mar;125(3):667–672. doi: 10.1016/0002-8703(93)90155-3. [DOI] [PubMed] [Google Scholar]
  24. Vaughan D. E., Lamas G. A., Pfeffer M. A. Role of left ventricular dysfunction in selective neurohumoral activation in the recovery phase of anterior wall acute myocardial infarction. Am J Cardiol. 1990 Sep 1;66(5):529–532. doi: 10.1016/0002-9149(90)90476-h. [DOI] [PubMed] [Google Scholar]
  25. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335–371. doi: 10.1016/s0033-0620(85)80003-7. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES